Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abengeo, abovementioned, absolute, ACAAI, academia, Academy, acceded, acceding, ACCELA, Accordi, acebutolol, Acetanol, acquitted, adrenal, advocacy, aflibercept, African, alcohol, alum, Ambler, AML, Amoban, Analytical, ANCARE, antiobesity, APHP, apnea, APOLLO, Aquilda, array, askinginter, asMinistre, ataciguat, ATPase, attrition, aut, Authorisation, bactericidal, Bangkok, Barcelona, Basel, BCS, belt, Benambax, benchmark, beneficiary, Bertelsmann, Bicker, bile, bioavailability, Bioenergy, bladder, blower, Bruno, Bulgarian, buoyant, buoyed, Carnrick, Castaigne, Catalent, Catalonia, causa, CBER, CEA, Cefotax, cefotaxime, certificationsagainst, Chase, childbearing, ChimeriVax, Citigroup, claimsinter, Claudie, clinician, CMV, ColeyPharmaceutical, combinatorial, combretastatin, Committeehold, concealed, concomitant, confirmatory, contact, converge, Coporation, copromote, copromoted, correlated, Cour, crystaline, cyclase, cytostatic, Danone, database, Dayton, deactivated, defective, desiring, Devaluation, dictate, dihydrochloride, disopyramide, drawdownsand, Dyax, easily, easy, ecotoxicity, edition, Eloxatine®in, enjoyed, ENSAM, envisaged, EORTC, Epargne, EPO, EPOC, ESA, ESC, ESH, ethical, everyday, expensesor, experimental, FDAAA, felodipine, FGF, fipronil, firing, Fisher, fitting, FOLFIRI, forbade, fortiori, fourteenth, fragmented, frame, Franzblau, fresh, fuel, fungible, futility, gender, generification, GenRX, Glioblastoma, Guangdong, guanylate, Gunter, haematological, haematology, haematopoietic, Haigner, hampered, Heidelberg, hereinafter, Hexaxim, honor, Hospira, Hubert, humoral, hypoglycemic, ICC, ICD, Idaho, idem, IDF, idrabiotaparinux, imbalance, IMI, immobilization, imperfect, implantable, Importantly, inability, inCumulative, indemnity, indoor, inequity, injuring, insomniac, intergovernmental, intradermal, invention, involuntarily, involuntary, Iowa, IPD, JAMA, JE, JEV, John, JPMorgan, jurisprudence, Justicia, keen, ketoprofen, kinesin, Klausenburg, Laboratory, Labour, Lag, Lancet, Lane, leaflet, learnt, leflunomide, levocetirizine, liter, LLRICE, Lonza, Louisiana, Loyalty, Lupin, Luscan, mAb, mandate, Markl, Menamin, METI, MEXT, mHRPC, MI, mice, MIR, mirroring, misleading, misused, mitotic, MoAB, mobility, Mssr, multi, multidose, MVA, Nasacort®AQ, neglected, Nerispirdine, newest, NHS, Nile, nosocomial, NPY, NRD, NRX, obligatory, ODT, Ontario, OptiClick, OptiPen, OptiSet, ora, orFinancial, Organisation, orthopaedic, orthopedic, osteoarthritic, ourstatutsof, outbreak, outdoor, outweigh, overactive, overdue, overpayment, paliroden, Panaldine, paperrelate, pared, pargne, PAT, Patrick, payback, payer, peer, pentamidine, phage, pharmacovigilance, PharmaSTAR, phosphodiester, physiologic, Pilar, Pisano, Placemen, PMDA, polysomnography, poor, PPSA, Preran, proactive, profibrinolytic, progam, Programma, propensity, prosecuted, prosecution, prostaglandin, Province, Publique, PUMA, purity, Ravetch, reabsorption, reactivated, reactivity, Reasearch, Reed, regained, remarkable, revascularization, revoking, rheumatologist, Rockefeller, Romanian, Rythmodan, SANAD, Santoni, sarcoma, scalability, scarcity, scent, scouting, script, securitization, sedative, sentenced, Seoul, seq, sera, seroprotection, serotype, serum, Servier, Shenzen, Shenzhen, shortening, signal, sizeable, slated, sliding, solicit, Somitomo, spatial, spirit, SSI, staggered, standpoint, Station, stem, Stiftung, stilnox®, subset, substantive, substantively, supplier, synthase, tachycardia, tachykinin, TAFIa, tamsulosin, taste, TechPharma, TecPharma, tetravalent, TheChairman, TheChief, thecompte, Thielen, thirteen, Tianjin, ticlopidine, trandolapril, TSJC, Ttype, unadjusted, unclassified, uncomplicatedPlasmodium, undeveloped, Unifive, uniform, Utah, Uwe, variant, VelocImmune, VelociSuite, Vero, Vinci, visible, Vision, Vivaldi, Volinanserin, warrant, WASO, weakening, West, Weymuller, whistle, widespread, wild, Ypsomed, Zimulti, zimulti®, zopiclone
Removed:
achieving, adjunctive, adjusting, amiodarone, amyotrophic, annum, APB, appellate, approvable, Armbruster, arranged, arrhythmic, au, averaged, barrister, biggest, Bristol, calculating, Campto, CAPA, CASPAR, Cephalon, chart, cheapest, Columbia, concomitantly, condensed, Connecticut, consolidating, contest, contrast, corridor, cortex, create, criminology, David, deciding, deconsolidation, dementia, demonstrable, dependency, derivation, devote, devoted, diagnostic, discourage, disqualification, drew, dual, EASD, Economica, EITF, element, engineer, enlarged, existed, Exit, expensesfor, exportation, FAS, FASB, fiscalmay, flexibility, forma, freeze, GAAP, great, grew, GSK, Hall, hcl, heard, hepatic, HFA, HHS, home, horizontal, hydrofluoroalkane, hypoxic, illustrative, impressive, inactive, inappropriate, inclusion, inconvenience, inhaler, inhibiting, insertion, installment, intensified, intercompany, Introgen, Jacquesson, Kerjouan, Laboratoire, LANMET, LAPTOP, LCO, letter, leucovorin, Loi, lowest, LV, Lybrand, magnitude, Maladie, maturation, metered, metformin, monocyte, multiplying, nationwide, neuronal, nicotinic, noted, obtainable, Organon, pact, pancreatic, Pharmacia, Pharmascience, pioneering, postretirement, prefrontal, premixed, profiling, Projet, Prontuario, Propulsion, Proskelia, quashing, rationale, recommend, reconcile, Relatif, reorganized, repayment, requisite, restored, rhythm, rio, Riva, Rothwell, round, Rupee, Scranton, secretion, sensory, servicing, Seton, showing, SIADH, SNPA, speed, standing, Strakan, studying, sustainable, swap, switching, Tavanic, tendered, thing, thrombolytic, Timothy, tirapazamine, tofinancial, tort, trained, Transkaryotic, triple, tyrosine, Uclaf, undistributed, uniquely, urinate, Uvidem, validating, Wellcome, Wyeth
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 1.1 Bylaws (Statuts) of Sanofi-aventis (English Translation)
- 12.1 Certification by Gerard Le Fur, Chief Executive Officer
- 12.2 Certification by Jean-claude Leroy, Principal Financial Officer
- 13.1 Certification by Gerard Le Fur, Chief Executive Officer
- 13.2 Certification by Jean-claude Leroy, Principal Financial Officer
- 23.1 Consent of Ernst & Young Audit
- 23.2 Consent of Pricewaterhousecoopers Audit
- 99.1 Report of the Chairman of the Board of Directors for 2007
- 99.2 Extract from the French Annual Report, Section 1.2 "Corporate Governance"
SNY similar filings
Filing view
External links